Comparison of Remifentanil and Dexmedetomidine for Monitored Anaesthesia Care During Vertebroplasty and Kyphoplasty

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

October 31, 2014

Conditions
Fractures, Compression
Interventions
DRUG

Remifentanil

Patients given remifentanil received continuous infusion of the drug at 1-5 µg/kg/h

DRUG

Dexmedetomidine

Patients receiving dexmedetomidine were given that drug at 0.3-0.4 µg/kg over 10 min, followed by continuous infusion of 0.2 1 µg/kg/h

DRUG

midazolam

All patients were premedicated with midazolam 0.02 mg/kg before induction.

DRUG

propofol

All patients in both groups received a bolus dose of propofol 0.3 mg/kg for sedative effect.

DRUG

ephedrine

Ephedrine 5 mg was injected when systolic blood pressure decreased below 90 mmHg

Trial Locations (1)

Unknown

Hallym University Sacred Heart Hospital, Anyang-si

All Listed Sponsors
lead

Hallym University Medical Center

OTHER

NCT02476981 - Comparison of Remifentanil and Dexmedetomidine for Monitored Anaesthesia Care During Vertebroplasty and Kyphoplasty | Biotech Hunter | Biotech Hunter